Filing Details
- Accession Number:
- 0000930413-18-003233
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-31 09:06:34
- Reporting Period:
- 2018-10-29
- Accepted Time:
- 2018-10-31 09:06:34
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 903568 | Elazar Rabbani | C/O Enzo Biochem, Inc. 527 Madison Avenue New York NY 10022 | Chm Of The Bd, Ceo And Sec | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-10-29 | 10,000 | $3.35 | 1,848,668 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
